89
Trump Admin Expands RSV Vaccinations to Adults Age 50+, Despite Recent Advisory Panel Shakeup
Washington D.C. – In a move signaling a potential shift in public health strategy, the Trump management is reportedly expanding eligibility for Respiratory Syncytial Virus (RSV) vaccinations to include adults aged 50 and older, a reduction from the previous age threshold of 60. This decision follows recommendations made by the now-disbanded Advisory Committee on Immunization practices (ACIP) [[1]].
RSV, while typically causing mild, cold-like symptoms, can pose a serious health risk – even be life-threatening – to infants and older adults. Current CDC guidelines recommend RSV vaccination for pregnant women and a one-time shot for individuals 75 years and older, with those 60+ with underlying health conditions also eligible
